CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

F. Guolo, L. Fianchi, P. Minetto, M. Clavio, M. Gottardi, S. Galimberti, G. Rizzuto, M. Rondoni, G. Bertani, M. Dargenio, A. Bilio, B. Scappini, P. Zappasodi, A.M. Scattolin, F. Grimaldi, G. Pietrantuono, P. Musto, M. Cerrano, S. D’Ardia, E. AudisioA. Cignetti, C. Pasciolla, F. Pavesi, A. Candoni, C. Gurreri, M. Morselli, C. Alati, N. Fracchiolla, G. Rossi, M. Caizzi, F. Carnevale-Schianca, A. Tafuri, F. Ferrara, L. Pagano, R.M. Lemoli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program'. Together they form a unique fingerprint.

Medicine & Life Sciences